Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock
Cathie Wood's biotech ETF has largely moved on from the vaccine maker.
Overview
On July 7, Cathie Wood's Ark Genomic Revolution ETF (NYSEMKT: ARKG) sold over 44,000 shares of BioNTech (NASDAQ: BNTX), a German immunotherapy maker. The next day, it sold over 78,000 shares, a transaction valued at around $7.4 million.
As of July 10, that left her asset management company with just 307 shares, valued at a little more than $28,000. Because Ark Invest holds positions worth millions of dollars and BioNTech is now the smallest holding in this entire exchange-traded fund (ETF), it may be fair to assume that Wood has moved on from BioNTech.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.